Yuhan, Hanmi fare well in first quarter

Published: 2013-05-07 06:58:00

Updated: 2013-05-07 06:58:00

Yuhan Corporation and Hanmi Pharmaceutical saw their first-quarter sales jump from a year before, while Dong-A Socio Holdings, Green Cross Corporation and Daewoong Pharmaceutical have still struggled to find their feet during the same quarter.

Sales of Dong-A Socio Holdings amounted to 215.6 b...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK